Skip to main content
Erschienen in: World Journal of Surgery 7/2018

Open Access 31.12.2017 | Original Scientific Report

Preoperative Prognostic Nutritional Index Predicts Long-Term Surgical Outcomes in Patients with Esophageal Squamous Cell Carcinoma

verfasst von: Noriyuki Hirahara, Yoshitsugu Tajima, Yusuke Fujii, Shunsuke Kaji, Tetsu Yamamoto, Ryoji Hyakudomi, Takahito Taniura, Yoshiko Miyazaki, Takashi Kishi, Yasunari Kawabata

Erschienen in: World Journal of Surgery | Ausgabe 7/2018

Abstract

Background

The purpose of the present study is to investigate the utility of prognostic nutritional index (PNI) as a simple and readily available marker in esophageal squamous cell carcinoma (ESCC).

Methods

We retrospectively analyzed 169 patients who underwent potentially curative esophagectomy, for histologically verified ESCC. We decided to set the optimal cutoff value for preoperative PNI levels at 49.2, based on the cancer-specific survival (CSS) and the overall survival (OS) by receiver operating characteristic curve analysis.

Results

Multivariate logistic regression analysis identified that TNM pStage III [hazard ratio (HR) 3.261, p < 0.0001] and PNI < 49.2 (HR 3.887, p < 0.0001) were confirmed as independent poor predictive factors for CSS, and age >70 (HR 2.024, p < 0.0042), TNM pStage III (HR 2.510, p = 0.0002), and PNI < 49.2 (HR 2.248, p = 0.0013) were confirmed as independent poor predictive factors for OS. In non-elderly patients, TNM pStage III (CSS; HR 3.488, p < 0.0001, OS; HR 2.615, p = 0.0007) and PNI < 49.2 (CSS; HR 3.849, p < 0.0001, OS; HR 2.275, p = 0.001) were confirmed as independent poor predictive factors for CSS, and OS when multivariate logistic regression analysis was applied. But in elderly patients, univariate analyses demonstrated that the TNM pStage III was the only significant risk factor for CSS (HR 3.701, p = 0.0057) and OS (HR 1.974, p = 0.0224).

Conclusions

The PNI was a significant and independent predictor of CSS and OS of ESCC patients after curative esophagectomy. The PNI was cost-effective and readily available, and it could act as a marker of survival.

Introduction

Esophageal cancer is a disease of the elderly, with peak incidence occurring in patients in their 70 s, and the elderly population is rapidly increasing in worldwide. Early detection and treatment confers the greatest chance of long-term survival in patients with esophageal cancer. However, a common problem among esophageal cancer patients (especially the elderly) is low tolerance to the available treatments, despite improvements in surgical techniques and perioperative care with reduced perioperative mortality after esophagectomy. Therefore, there is a continuing interest in prognostic factors to identify patients who are at greater risks of recurrence in order to better tailor individual treatments to those who are more likely to benefit from them. Progression and prognosis of cancer has been shown to be impacted by both the tumor features as well as the patient’s nutritional and immunologic status [1, 2]. Several screening tools are now available for assessing the preoperative nutritional status of patients with cancer, including the subjective global assessment, nutritional risk scoring 2002, body mass index, Glasgow Prognostic Score, and prognostic nutritional index (PNI) [36]. Many studies have addressed the association between preoperative nutritional status and postoperative outcomes. However, there is little data to show the impact of nutritional status on long-term outcomes in patients undergoing radical thoracoscopic esophagectomy for esophageal squamous cell carcinoma (ESCC) [7, 8].
The PNI was originally developed to predict the risk of postoperative morbidity and mortality after gastrointestinal surgery [9]. However, the method for calculating PNI is complicated and difficult to use routinely in clinical practice. In contrast, the simplified PNI proposed by Onodera et al. [6] can be easily measured because it is based on only two laboratory parameters, namely the serum albumin level and the peripheral blood lymphocyte count. Albumin is a widely used parameter of nutrition, and its levels have been shown to correlate well with postoperative complications and long-term outcomes in several malignancies [10]. Similarly, reduced lymphocyte count and function also correlate with poor prognosis, by enabling cancer cells to escape immune surveillance [11]. PNI, therefore, is a favorable indicator and is more reflective of the overall status of cancer patients.
In the management of cancer patients, there has been a continuing interest in preoperative prognostic indicators that can allow more accurate patient stratification, precise clinical decision-making, and improvement of short- and long-term outcomes. The TNM classification is widely used as a good standard prognostic indicator of patients with cancer [12]. However, since it includes pathological findings of the tumor, a conclusive classification can only be made postoperatively. In contrast, the PNI is based on the preoperative laboratory data alone and could be a comprehensive indicator of postoperative morbidity, mortality, and prognosis of cancer patients prior to surgery.
Therefore, we have demonstrated the prognostic significance of the simplified PNI in overall and age-stratified ESCC patients with a low versus high PNI, and evaluated its potential as a useful surrogate marker for predicting postoperative patient survival.

Methods

Patients

We retrospectively reviewed a database containing data from 169 patients who underwent potentially curative esophagectomy with R0 resection, for histologically verified ESCC in our institute, between January 2006 and December 2015. R0 resection was defined as complete tumor removal without the involvement of any microscopic resection margin. Video-assisted or thoracoscopic subtotal esophagectomy with three-field lymph node dissection was performed for all patients, followed by laparoscopic gastric surgery with an elevation of the gastric conduit to the neck via the posterior mediastinal approach or retrosternal approach with an end-to-end anastomosis of the cervical esophagus and gastric conduit. The patients’ clinical characteristics, laboratory data, treatment regimen, and pathological data were obtained from their medical records. None of the patients had clinical signs of infection or other systemic inflammatory conditions preoperatively. In this study, we excluded patients who had received pre- or postoperative adjuvant chemotherapy and/or radiotherapy.
We introduced a perioperative multidisciplinary management team, including surgeon, anesthesiologist, dental hygienist doctor, pharmacist, nutritionist, and rehabilitation technician, and certified expert surgical nurse, which aimed to decrease the incidence rate of postoperative complications. This team mainly managed dental cleaning, medication assistance, physical exercise and rehabilitation, respiratory training, and nutritional support. We provided preoperative enteral nutrition to optimize preoperative condition as possible.
The severity of postoperative complications was evaluated according to the Clavien–Dindo classification, and grade II or higher was recorded as a postoperative complication [13].
We evaluated cancer-specific survival (CSS) and overall survival (OS) as the endpoints of the study. The observation period started from the day of the operation and lasted for up to 5 years, loss to follow-up, withdrawal of consent, or until death. CSS was defined as the interval from the date of operation to the date of cancer-specific death or the last follow-up. Two patients who died of myocardial infarction within 60 days after esophagectomy were excluded from the analysis. We defined ‘elderly’ patients as those aged 70 years or older and ‘non-elderly’ as those aged less than 70 years of age [14].
Permission to perform this retrospective study was obtained from the ethical board of our institution and the study was conducted in accordance with the Declaration of Helsinki.

Preoperative calculation of the PNI and its cutoff value

The preoperative PNI was calculated using the following formula: 10 × serum albumin (g/dl) + 0.005 × total lymphocyte count (per mm3) in peripheral blood [6].
The receiver operating characteristics (ROC) curve of preoperative PNI levels was generated for multiple logistic regression analysis using CSS and OS. The area under the curve (AUC) estimation was used to assess the predictive ability of the PNI.
We decided to set the optimal cutoff value for preoperative PNI levels at 49.2 in this study, based on the CSS (sensitivity: 52.99%; specificity: 80.77%; AUC of the ROC curve: 0.653) and the OS (sensitivity: 52.63%; specificity: 70.27%; AUC of the ROC curve: 0.6132) at 5 years after surgery (Fig. 1). Based on their PNI values, patients were categorized as having a high PNI (49.2 or greater) or as having a low PNI (less than 49.2).

TNM pathological Stage (pStage)

The pathological classification of the primary tumor, the degree of lymph node involvement, and the presence of organ metastasis were determined according to the TNM classification system (7th edition of the cancer staging manual of the American Joint Committee on Cancer) [15].

Statistical analysis

The mean and standard deviation were calculated, and the differences were analyzed using Student’s t test. Differences between the various clinicopathological features were analyzed using the Chi-square test. The CSS was analyzed using Kaplan–Meier statistics, and inter-group differences were assessed using the log-rank test.
Univariate analyses were performed to determine variables associated with CSS. Variables with p values < 0.05 in the univariate analyses were included in a multivariate logistic regression analysis. The potential prognostic factors assessed were as follows: age (<70 vs. ≥70 years), sex (female vs. male), TNM pStage (I/II vs. III), tumor size (<3 vs. ≥3 cm), operation time (<600 vs. ≥600 min), intraoperative blood loss (<500 vs. ≥500 mL), serum squamous cell carcinoma antigen (SCC) value (<1.5 vs. ≥1.5), and PNI (<49.2 vs. ≥49.2).
All statistical analyses were performed using the statistical software JMP (version 11 for Windows; SAS Institute, Cary, NC), and p values <0.05 were considered statistically significant.

Results

Relationship between PNI and clinicopathological features

The correlation between the PNI and clinicopathological parameters in the 169 patients enrolled in this study is summarized in Table 1. The preoperative mean value of the PNI in this study was 47.3 ± 6.2, ranging from 26.8 to 65.7. Based on the cutoff value of 49.2, 98 patients (58%) were in the low PNI category and 71 patients (42%) were in the high PNI category. The results of our analysis showed that the PNI value correlated significantly with lymphocyte count (p < 0.0001), tumor size (p = 0.0327), depth of tumor (p < 0.0001), TNM pStage (p = 0.0005), SCC antigen level (p = 0.0072), albumin level (p < 0.0001), and CRP level (p = 0.0012).
Table 1
Relationships between PNI and clinicopathological features in 169 patients with esophageal cancer
Characteristics
Total patients
PNI
<49.2
(n = 98)
≥49.2
(n = 71)
p value
Age (years)
 
67.1 ± 8.2
65.4 ± 8.0
0.1804
Sex
   
0.628
 Male
150
86
64
 
 Female
19
12
7
 
WBC
 
5830.0 ± 2404.6
6233.9 ± 1616.6
0.2209
 Neutrophil
 
3773.6 ± 2197.3
3669.2 ± 1264.6
0.7199
 Lymphocyte
 
1396.4 ± 562.7
1931.8 ± 599.2
<0.0001
Platelet
 
232.8 ± 75.5
225.5 ± 50.2
0.4796
Location of tumor
   
0.0696
 Ce
13
12
1
 
 Ut
10
6
4
 
 Mt
73
39
34
 
 Lt
59
31
28
 
 Ae
14
10
4
 
Tumor size (mm)
 
5.27 ± 4.98
3.88 ± 2.53
0.0327
Depth of tumor
   
<0.0001
 T1a–1b
72
27
45
 
 2
13
8
5
 
 3
67
48
19
 
 4a–4b
17
15
2
 
Lymph node metastasis
   
0.1573
 N0
89
49
40
 
 N1
48
28
20
 
 N2
18
9
9
 
 N3
14
12
2
 
Pathological stage
   
0.0005
 1a–1b
62
24
38
 
 2a–2b
39
28
11
 
 3a–3c
68
46
22
 
Operation time (min)
 
656.1 ± 196.1
646.7 ± 158.6
0.7391
Intraoperative blood loss (ml)
 
665.5 ± 601.2
580.0 ± 612.3
0.3666
SCC antigen
 
1.67 ± 2.04
0.97 ± 0.85
0.0072
Albumin
 
3.64 ± 0.43
4.32 ± 0.30
<0.0001
CRP
 
0.658 ± 1.098
0.217 ± 0.314
0.0012

Prognostic factors for postoperative survival in patients with ESCC

Univariate analyses identified advanced TNM pStage [hazard ratio (HR), 4.170; 95% confidence interval (CI), 2.377–7.525; p < 0.0001], large tumor size (HR 1.854; 95% CI 1.093–3.678; p = 0.0233), prolonged operation time (HR 1.756; 95% CI 1.012–3.035; p = 0.0452), and low PNI (HR 4.566; 95% CI 2.375–9.674; p < 0.0001) as significant risk factors for shorter CSS. The TNM pStage (HR 3.261; 95% CI 1.808–6.043; p < 0.0001) and PNI (HR 3.887; 95% CI 1.999–8.309; p < 0.0001) were confirmed as independent prognostic factors for CSS when multivariate logistic regression analysis was applied (Table 2).
Table 2
Prognostic factors for cancer-specific survival in patients with esophageal cancer
Variables
Patients (n = 169)
Category or characteristics
Univariate
Multivariate
HR
95% CI
p value
HR
95% CI
p value
Gender
19/150
(Female/male)
1.14
0.499–3.290
0.7765
   
Age
59/110
(<70/≥70)
1.42
0.790–2.480
0.2344
   
TNM pStage
101/68
(1,2/3)
4.17
2.377–7.525
<0.0001
3.261
1.808–6.043
<0.0001
Tumor size
64/105
(<3/≥3)
1.854
1.093–3.678
0.0233
1.076
0.583–2.079
0.8203
Operation time
111/58
(<600/≥600)
1.756
1.012–3.035
0.0452
1.595
0.910–2.786
0.1024
Intraoperative blood loss
87/82
(<500/≥500)
0.973
0.562–1.685
0.9226
   
PNI
98/71
(≥49.2/<49.2)
4.566
2.375–9.674
<0.0001
3.887
1.999–8.309
<0.0001
SCC
126/43
(<1.5/≥1.5)
1.169
0.584–2.171
0.6425
   
Univariate analyses identified advanced age (HR 1.930; 95% CI 1.205–3.061; p = 0.0066), advanced TNM pStage (HR 2.725; 95% CI 1.714–4.349; p < 0.0001), large tumor size (HR 1.868; 95% CI 1.149–3.141; p = 0.0112), and low PNI (HR 2.612; 95% CI 1.600–4.405; p < 0.0001) as significant risk factors for shorter OS. The age (HR 2.024; 95% CI 1.255–3.236; p = 0.0042), TNM pStage (HR 2.510; 95% CI 1.555–4.064; p = 0.0002), and PNI (HR 2.248; 95% CI 1.362–3.832; p = 0.0013) were confirmed as independent prognostic factors for OS in multivariate logistic regression analysis (Table 3).
Table 3
Prognostic factors for overall survival in patients with esophageal cancer
Variables
Patients(n = 169)
Category or characteristics
Univariate
Multivariate
HR
95% CI
p value
HR
95% CI
p value
Gender
19/150
(Female/male)
1.12
0.550–2.687
0.773
   
Age
59/110
(<70/≥70)
1.93
1.205–3.061
0.0066
2.024
1.255–3.236
0.0042
TNM pStage
101/68
(1,2/3)
2.725
1.714–4.349
<0.0001
2.51
1.555–4.065
0.0002
Tumor size
64/105
(<3/≥3)
1.868
1.149–3.141
0.0112
1.219
0.7364–2.083
0.5582
Operation time
111/58
(<600/≥600)
1.481
0.9288–2.344
0.0981
   
Intraoperative blood loss
87/82
(<500/≥500)
1.308
0.825–2.098
0.2541
   
PNI
98/71
(≥49.2/<49.2)
2.612
1.600–4.405
<0.0001
2.248
1.362–3.832
0.0013
SCC
126/43
(<1.5/≥1.5)
1.589
0.934–2.609
0.0859
   

Prognostic factors for postoperative survival in non-elderly patients with ESCC

Among 110 non-elderly patients, univariate analyses identified advanced TNM pStage (HR 4.646; 95% CI 2.281–10.027; p < 0.0001), large tumor size (HR 2.872; 95% CI 1.349–6.825; p = 0.0054), and low PNI (HR 11.370; 95% CI 4.040–47.500; p < 0.0001) as significant risk factors for shorter CSS. The TNM pStage (HR 3.488; 95% CI 1.948–6.424; p < 0.0001) and PNI (HR 3.849; 95% CI 1.987–8.205; p < 0.0001) were confirmed as independent prognostic factors for CSS when multivariate logistic regression analysis was applied (Table 4).
Table 4
Univariate and multivariate analysis of cancer-specific survival in 110 non-elderly patients with esophageal cancer
Variables
Patients (n = 110)
Category or characteristics
Univariate
Multivariate
HR
95% CI
p value
HR
95% CI
p value
Gender
11/99
(Female/male)
0.865
0.307–3.612
0.8142
   
TNM pStage
64/46
(1,2/3)
4.646
2.281–10.027
<0.0001
3.488
1.948–6.424
<0.0001
Tumor size
44/66
(<3/≥3)
2.872
1.349–6.825
0.0054
1.115
0.607–2.149
0.7313
Operation time
74/36
(<600/≥600)
1.636
0.307–1.234
0.1664
   
Intraoperative blood loss
55/55
(<500/≥500)
1.176
0.591–2.371
0.6437
   
PNI
61/49
(≥49.2/<49.2)
11.37
4.040–47.500
<0.0001
3.849
1.987–8.205
<0.0001
SCC
83/27
(<1.5/≥1.5)
1.307
0.516–2.914
0.5471
   
Univariate analyses identified advanced TNM pStage (HR 3.772; 95% CI 2.027–7.234; p < 0.0001), large tumor size (HR 2.539; 95% CI 1.315-5.298; p = 0.0050), and low PNI (HR 3.671; 95% CI 1.864–7.897; p = 0.0001) as significant risk factors for shorter OS. The TNM pStage (HR 2.615; 95% CI 1.430–3.768; p = 0.0007) and PNI (HR 2.275; 95% CI 1.384–3.863; p = 0.001) were confirmed as independent prognostic factors for OS in multivariate logistic regression analysis (Table 5).
Table 5
Univariate and multivariate analysis of overall survival in 110 non-elderly patients with esophageal cancer
Variables
Patients (n = 110)
Category or characteristics
Univariate
Multivariate
HR
95% CI
p value
HR
95% CI
p value
Gender
11/99
(Female/male)
1.08
0.390–4.478
0.8968
   
TNM Stage
64/46
(1,2/3)
3.772
2.027–7.234
<0.0001
2.615
1.430–3.768
0.0007
Tumor size
44/66
(<3/≥3)
2.539
1.315–5.298
0.005
1.281
0.769–2.202
0.3477
Operation time
74/36
(<600/≥600)
1.254
0.661–2.320
0.4803
   
Intraoperative blood loss
55/55
(<500/≥500)
1.524
0.822–2.911
0.1821
   
PNI
61/49
(≥49.2/<49.2)
3.671
1.864–7.897
0.0001
2.275
1.384–3.863
0.001
SCC
83/27
(<1.5/≥1.5)
1.515
0.697–3.028
0.2787
   

Prognostic factors for postoperative survival in elderly patients with ESCC

In 59 elderly patients, univariate analyses demonstrated that the TNM pStage was the only significant risk factor for shorter CSS and OS (HR 3.701; 95% CI 1.470–9.743; p = 0.0057, HR 1.974; 95% CI 0.938–4.038; p = 0.0224, respectively) (Table 6).
Table 6
Univariate and multivariate analysis of cancer-specific survival and overall survival in 59 elderly patients with esophageal cancer
Variables
Patients (n = 59)
Category or characteristics
Cancer-specific survival
Univariate
Overall survival
Univariate
HR
95% CI
p value
HR
95% CI
p value
Gender
8/51
(Female/male)
1.85
0.526–11.717
0.3755
1.577
0.615–5.349
0.37
TNM pStage
37/22
(1,2/3)
3.701
1.470–9.743
0.0057
1.974
0.938–4.038
0.0224
Tumor size
20/39
(<3/≥3)
0.973
0.390–2.623
0.9542
1.073
0.526–2.313
0.8507
Operation time
37/22
(<600/≥600)
1.909
0.768–4.815
0.1614
1.731
0.859–3.491
0.1235
Intraoperative blood loss
32/27
(<500/≥500)
0.689
0.265–1.714
0.4235
1.023
0.506–2.088
0.9493
PNI
37/22
(≥49.2/<49.2)
1.68
0.655–4.679
0.2838
1.748
0.845–3.784
0.1333
SCC
43/16
(<1.5/≥1.5)
1.218
0.387–3.287
0.715
2.003
0.909–4.214
0.0828

PNI and postoperative survival in all patients with ESCC

Kaplan–Meier analysis and the log-rank test demonstrated that patients with a low PNI had a significantly worse prognosis in terms of CSS and OS than those with a high PNI (p < 0.0001, and p = 0.0003, respectively). The 5-year CSS rates were 46.5 and 84.2%, and the 5-year OS rates were 38.3 and 74.1% for patients with a low PNI and a high PNI, respectively (Fig. 2).

PNI and postoperative survival in non-elderly patients with ESCC

Kaplan–Meier analysis and the log-rank test demonstrated that patients with a low PNI had a significantly worse prognosis in terms of CSS and OS than those with a high PNI (p < 0.0001, and p = 0.0003, respectively). The 5-year CSS rates were 44.1, and 92.8% and the 5-year OS rates were 41.5 and 84.8% for patients with a low PNI and a high PNI, respectively (Fig. 3).

PNI and postoperative survival in elderly patients with ESCC

Kaplan–Meier analysis and the log-rank test showed no significant relationship between PNI and CSS (p = 0.1398) or OS (p = 0.1907) in elderly patients with ESCC (Fig. 4).

PNI and postoperative complications

The postoperative complications in the high and low PNI groups are shown in Table 7. No significant differences in incidence rates of postoperative complication were observed between overall and age-stratified patients with a low versus high PNI. Similarly, there were no significant differences in postoperative hospital stay (data not shown).
Table 7
Comparison between postoperative complications and PNI
 
Overall patients
PNI
Non-elderly patients
PNI
Elderly patients
PNI
<49.2
≥49.2
p value
<49.2
≥49.2
p value
<49.2
≥49.2
p value
(n = 169)
n (%)
(n = 98)
n (%)
(n = 71)
n (%)
(n = 110)
n (%)
(n = 61)
n (%)
(n = 49)
n (%)
(n = 59)
n (%)
(n = 37)
n (%)
(n = 22)
n (%)
Anastomotic leakage
17 (10.1)
9 (9.2)
8 (11.3)
0.657
8 (7.3)
4 (6.6)
4 (8.2)
0.747
9 (15.2)
5 (13.5)
4 (18.2)
0.63
Vocal code paresis
11 (6.5)
6 (6.1)
5 (7.0)
0.811
4 (3.6)
2 (3.3)
2 (4.1)
0.823
7 (11.9)
4 (10.8)
3 (13.6)
0.746
Pulmonary complication
48 (28.4)
30 (30.6)
18 (25.4)
0.454
20 (18.2)
12 (19.7)
8 (16.3)
0.651
28 (47.5)
18 (48.6)
10 (45.5)
0.812
Chylothorax
1 (0.6)
0 (0)
1 (1.4)
0.239
1 (0.9)
1 (1.6)
0 (0)
0.368
0 (0)
0 (0)
0 (0)
NaN
Surgical site infection
10 (5.9)
4 (4.1)
6 (8.5)
0.235
5 (4.5)
2 (3.3)
3 (6.1)
0.477
5 (8.5)
2 (5.4)
3 (13.6)
0.272
NaN Not a number

Discussion

Treatment strategies for ESCC include surgery, radiation, chemotherapy, or a combination thereof. Although a complete surgical resection of the tumor offers a chance for cure, the rate of disease recurrence is very high in ESCC even after an aggressive surgery. Histopathology of surgical specimens is widely used to estimate the prognosis after surgery [12]; however, its predictive value is still limited. The precise evaluation of the risk of postoperative recurrence is important in planning a customized risk-adapted therapeutic strategy for individual patients. In particular, identifying prognostic factors prior to surgery is important to determine the optimal preoperative therapy, and to improve postoperative short- and long-term outcomes [16]. The original PNI consists of tests measuring albumin, transferrin, triceps skin fold, and skin sensitivity reaction to common antigens [17], and it was developed to assess the perioperative complications, including anastomotic leakage, delayed tissue repair, and length of hospital stay in patients undergoing gastrointestinal surgery [11, 18]. The simplified PNI, on the other hand, consists of only two laboratory parameters, namely serum albumin concentration and total lymphocyte count in the peripheral blood [6], both of which are measured routinely in clinical practice. Recently, several studies have reported that albumin is produced by hepatocytes and is regulated by pro-inflammatory cytokines, including interleukin-1 (IL-1), IL-6, and tumor necrosis factor-α (TNF-α) that adversely affect catabolic metabolism [1921]. These cytokines produced by either the tumor itself or the host are crucial for carcinogenesis, cancer progression, and neo-angiogenesis. In addition, albumin has been shown to help stabilize cell growth and DNA replication, buffer a variety of biochemical changes and maintain sex hormone homeostasis to protect against tumorigenesis [10]. Albumin, therefore, is reflective of the inflammation and immune status of cancer, although it alone is not sufficient to predict the final outcome in cancer patients. Another element of the simplified PNI is the lymphocyte count. Lymphocytes are one of the fundamental components of cell-mediated immunity with inhibitory effects on the proliferation and invasion of tumor cells via cytokine-mediated cytotoxicity [11, 22]. Most patients with ESCC are malnourished, either due to poor dietary intake, protein loss from the primary lesion or due to catabolic metabolism [23]. Impaired nutritional and immunologic status accelerates tumor progression due to a decline in tumor immunity [16, 22]. The PNI is, therefore, a comprehensive indicator of the nutritional and immunologic status in cancer patients [24].
In this study, we evaluated the potential of simplified PNI as a prognostic marker of CSS and OS in ESCC patients who underwent radical thoracoscopic esophagectomy. Patients with a low PNI (less than 49.2) showed a significantly shorter CSS and decreased OS in comparison with patients who had a high PNI (49.2 or greater). This is consistent with our finding that PNI is inversely related to the stage of cancer, the value being lower in patients with a larger, deeper and more aggressive tumor at an advanced TNM pStage [25]. Recent studies have also demonstrated an association between the occurrences of postoperative complications with deteriorated CSS in patients with gastrointestinal cancer [26, 27]. Patients with a low PNI are, therefore, more likely to develop postoperative complications [11, 17, 18], including a systemic inflammatory response, which can also contribute to the decreased CSS and OS. However, this correlation between PNI and CSS/OS was found only in non-elderly patients and not in the elderly patients. This difference could be due to the fact that irrespective of being a cancer patient or not, hypoalbuminemia and leukocytopenia are often associated with aging, leading to malnutrition and immune suppression [28]. Previous studies have reported that cancer patients experiencing postoperative complications generally have a poorer prognosis [2931]. Because patients with a low preoperative PNI value are at a high risk of postoperative complications, the preoperative PNI value may affect both postoperative short- and long-term outcomes. However, in this study, no significant differences were observed between the PNI value and the rate of postoperative complications. Therefore, further studies are thus needed to address this issue.
The optimal cutoff points for PNI in predicting postoperative survival in patients with malignant tumors is still controversial. Thus, one of the aims of this study was to evaluate the prognostic value of the PNI and propose an optimal cutoff, which can predict CSS and OS with better accuracy, in patients with ESCC. Based on our study of 169 patients who underwent curative esophagectomy, and using a ROC curve, we have arrived at 49.2 as the cutoff value for PNI. The cutoff value for PNI in ESCC patients seems to be much lower than those reported in another cancer, such as renal cell carcinoma, lung cancer, and gliomas [3234]. The possible reason may be that most ESCC patients have some degree of swallowing difficulty due to obstruction or stricture of the esophagus, which results in the eating disorder, malnutrition, and subsequent poor nutritional status [35].
Several limitations should be considered when interpreting the results of this study. The retrospective nature and a single-institution study, the involvement of a comparatively small sample size, and short follow-up periods were the major limitations of this study. Minor limitations included insufficient evidence of the validity of the cutoff values for the PNI. Regarding the PNI, a fixed cutoff value has not yet been established, and various values have been used in previous reports. Another limitation was that some other parameters involved in systemic inflammation, such as TNF-α and interleukins were not studied, since, these inflammatory parameters are not routinely tested in clinical practice caused by its high cost and inconvenience.
Previous studies have shown that perioperative immunonutrition support improves both nutritional and immunologic status of patients undergoing elective surgeries, thereby reducing postoperative morbidity and mortality [9, 36]. However, it is still unknown whether such nutritional intervention can help improve the surgical outcomes in patients with a low PNI. A larger randomized multicenter prospective study is required to help determine this.

Compliance with ethical standards

Conflict of interest

None of the authors have any conflicts of interest.

Ethical approval

All procedures performed in the study involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Unsere Produktempfehlungen

Die Chirurgie

Print-Titel

Das Abo mit mehr Tiefe

Mit der Zeitschrift Die Chirurgie erhalten Sie zusätzlich Online-Zugriff auf weitere 43 chirurgische Fachzeitschriften, CME-Fortbildungen, Webinare, Vorbereitungskursen zur Facharztprüfung und die digitale Enzyklopädie e.Medpedia.

Bis 30. April 2024 bestellen und im ersten Jahr nur 199 € zahlen!

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

© Springer Medizin

Bis 11. April 2024 bestellen und im ersten Jahr 50 % sparen!

Literatur
1.
Zurück zum Zitat Mainous MR, Deitch EA (1994) Nutrition and infection. Surg Clin N Am 74(3):659–676PubMed Mainous MR, Deitch EA (1994) Nutrition and infection. Surg Clin N Am 74(3):659–676PubMed
3.
Zurück zum Zitat Weimann A, Braga M, Harsanyi L et al (2006) ESPEN guidelines on enteral nutrition: surgery including organ transplantation. Clin Nutr 25:224–244CrossRefPubMed Weimann A, Braga M, Harsanyi L et al (2006) ESPEN guidelines on enteral nutrition: surgery including organ transplantation. Clin Nutr 25:224–244CrossRefPubMed
5.
Zurück zum Zitat Forrest LM, McMillan DC, McArdle CS et al (2004) Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer. Br J Cancer 90:1704–1706CrossRefPubMedPubMedCentral Forrest LM, McMillan DC, McArdle CS et al (2004) Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer. Br J Cancer 90:1704–1706CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Onodera T, Goseki N, Kosaki G (1984) Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi 85:1001–1005 (in Japanese) PubMed Onodera T, Goseki N, Kosaki G (1984) Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi 85:1001–1005 (in Japanese) PubMed
9.
Zurück zum Zitat Smale BF, Mullen JL, Buzby GP et al (1981) The efficacy of nutritional assessment and support in cancer surgery. Cancer 47:2375–2381CrossRefPubMed Smale BF, Mullen JL, Buzby GP et al (1981) The efficacy of nutritional assessment and support in cancer surgery. Cancer 47:2375–2381CrossRefPubMed
13.
Zurück zum Zitat Dind D, Demartines N, Clavien PS (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRef Dind D, Demartines N, Clavien PS (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRef
14.
Zurück zum Zitat Pohl H, Welch HG (2005) The role of over diagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 97:142–146CrossRefPubMed Pohl H, Welch HG (2005) The role of over diagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 97:142–146CrossRefPubMed
15.
Zurück zum Zitat Sobin LH, Gospodarowicz MK, Wittekind CH (2009) TNM classification of malignant tumours, 7th edn. Willey, Hoboken Sobin LH, Gospodarowicz MK, Wittekind CH (2009) TNM classification of malignant tumours, 7th edn. Willey, Hoboken
16.
Zurück zum Zitat Lien YC, Hsieh CC, Wu YC et al (2004) Preoperative serum albumin level is a prognostic indicator for adenocarcinoma of the gastric cardia. J Gastointest Surg 8:1041–1048CrossRef Lien YC, Hsieh CC, Wu YC et al (2004) Preoperative serum albumin level is a prognostic indicator for adenocarcinoma of the gastric cardia. J Gastointest Surg 8:1041–1048CrossRef
17.
Zurück zum Zitat Buzby GP, Mullen JL, Matthews DC et al (1980) Prognostic nutritional index in gastrointestinal surgery. Am J Surg 139:160–167CrossRefPubMed Buzby GP, Mullen JL, Matthews DC et al (1980) Prognostic nutritional index in gastrointestinal surgery. Am J Surg 139:160–167CrossRefPubMed
24.
Zurück zum Zitat Esper DH, Harb WA (2005) The cancer cachexia syndrome: a review of metabolic and clinical manifestations. Nutr Clin Pract 20:369–376CrossRefPubMed Esper DH, Harb WA (2005) The cancer cachexia syndrome: a review of metabolic and clinical manifestations. Nutr Clin Pract 20:369–376CrossRefPubMed
28.
Zurück zum Zitat Ahmed T, Haboubi N (2010) Assessment and management of nutrition in older people and its importance to health. Clin Interv Aging 5:207–216PubMedPubMedCentral Ahmed T, Haboubi N (2010) Assessment and management of nutrition in older people and its importance to health. Clin Interv Aging 5:207–216PubMedPubMedCentral
29.
Zurück zum Zitat Aoyama T, Murakawa M, Katayama Y et al (2015) Impact of postoperative complications on sutvival and recurrence inpancreatic cancer. Anticancer Res 35:2401–2409PubMed Aoyama T, Murakawa M, Katayama Y et al (2015) Impact of postoperative complications on sutvival and recurrence inpancreatic cancer. Anticancer Res 35:2401–2409PubMed
33.
Metadaten
Titel
Preoperative Prognostic Nutritional Index Predicts Long-Term Surgical Outcomes in Patients with Esophageal Squamous Cell Carcinoma
verfasst von
Noriyuki Hirahara
Yoshitsugu Tajima
Yusuke Fujii
Shunsuke Kaji
Tetsu Yamamoto
Ryoji Hyakudomi
Takahito Taniura
Yoshiko Miyazaki
Takashi Kishi
Yasunari Kawabata
Publikationsdatum
31.12.2017
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 7/2018
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-017-4437-1

Weitere Artikel der Ausgabe 7/2018

World Journal of Surgery 7/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.